{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06296836",
            "orgStudyIdInfo": {
                "id": "2024-001"
            },
            "organization": {
                "fullName": "University of Illinois at Chicago",
                "class": "OTHER"
            },
            "briefTitle": "Effect of Continuing Versus Holding Metformin During Hospitalizations.",
            "officialTitle": "Effect of Continuing Versus Holding Metformin During Hospitalizations to Internal Medicine on Glucose Control, Acidosis, Abdominal Symptoms, Length of Stay, and Mortality.",
            "therapeuticArea": [
                "Endocrinology"
            ],
            "study": "effect-of-continuing-versus-holding-metformin-during-hospitalizations"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-02",
            "overallStatus": "NOT_YET_RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-04-01",
                "type": "ESTIMATED"
            },
            "primaryCompletionDateStruct": {
                "date": "2026-03-31",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2026-06-30",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2024-02-29",
            "studyFirstSubmitQcDate": "2024-02-29",
            "studyFirstPostDateStruct": {
                "date": "2024-03-06",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-02-29",
            "lastUpdatePostDateStruct": {
                "date": "2024-03-06",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "University of Illinois at Chicago",
                "class": "OTHER"
            },
            "collaborators": [
                {
                    "name": "Emily Hanners",
                    "class": "UNKNOWN"
                },
                {
                    "name": "Dulal Bhaumik",
                    "class": "UNKNOWN"
                },
                {
                    "name": "Avisek Datta",
                    "class": "UNKNOWN"
                },
                {
                    "name": "Peggy Choye",
                    "class": "UNKNOWN"
                },
                {
                    "name": "Hailey Soni",
                    "class": "UNKNOWN"
                },
                {
                    "name": "Annesti Elmasri",
                    "class": "UNKNOWN"
                },
                {
                    "name": "Julie Jun",
                    "class": "UNKNOWN"
                },
                {
                    "name": "Colin Goodman",
                    "class": "UNKNOWN"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false,
            "isUsExport": false
        },
        "descriptionModule": {
            "briefSummary": "A randomized study of continuing versus holding metformin during hospitalizations to internal medicine services to determine the effects on glucose control, acidosis, abdominal symptoms, length of stay, and mortality.",
            "detailedDescription": "The purpose of this study is to determine what the effects of the routine practice of holding metformin in hospitalized patients with type 2 diabetes are on outcomes.\n\nThe objectives of this study are to determine how holding versus continuing metformin during hospitalization to an internal medicine service affects the incidences of lactic acidosis, mean anion gap, mean glucose levels, low and very high blood sugars, GI effects after discharge, lack of continuation of metformin upon discharge, mean glucose levels, lengths of stay, and 30-day mortality."
        },
        "conditionsModule": {
            "conditions": [
                "Diabetes Mellitus, Type 2"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE4"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "interventionModelDescription": "Randomized, parallel, prospective trial.",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 300,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Metformin continuation",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "Continuation of home metformin regimen during hospitalization to an internal medicine service",
                    "interventionNames": [
                        "Drug: Metformin"
                    ]
                },
                {
                    "label": "Metformin discontinuation",
                    "type": "NO_INTERVENTION",
                    "description": "Holding home metformin regimen during hospitalization to an internal medicine service"
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Metformin",
                    "description": "Continuation of home metformin",
                    "armGroupLabels": [
                        "Metformin continuation"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Mean glucose levels",
                    "description": "Average of daily glucose levels during hospitalization",
                    "timeFrame": "During hospitalization"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Incidence of hyperglycemia greater than 300 mg/dl.",
                    "timeFrame": "During hospitalization"
                },
                {
                    "measure": "Incidence of hypoglycemia (Glu = 54 - 70).",
                    "timeFrame": "During hospitalization"
                },
                {
                    "measure": "Incidence of moderate hypoglycemia (Glu < 54)",
                    "timeFrame": "During hospitalization"
                },
                {
                    "measure": "Incidence of severe hypoglycemia (Glu < 54 with symptoms)",
                    "timeFrame": "During hospitalization"
                },
                {
                    "measure": "Mean lactic acid levels.",
                    "timeFrame": "During hospitalization"
                },
                {
                    "measure": "Incidence of lactic acid levels greater than 2.0.",
                    "timeFrame": "During hospitalization"
                },
                {
                    "measure": "Mean anion gap.",
                    "timeFrame": "During hospitalization"
                },
                {
                    "measure": "Incidence of anion gap > 11",
                    "timeFrame": "During hospitalization"
                },
                {
                    "measure": "Incidence of elevated lactic acid level or anion gap.",
                    "timeFrame": "During hospitalization"
                },
                {
                    "measure": "Incidence of inadvertently not continuing metformin on discharge",
                    "timeFrame": "At discharge"
                },
                {
                    "measure": "GI adverse effects",
                    "timeFrame": "Within 3 days of discharge"
                },
                {
                    "measure": "Mortality",
                    "timeFrame": "30 +/- 3 days after discharge"
                }
            ],
            "otherOutcomes": [
                {
                    "measure": "Mean glucose levels while receiving metformin in the continuation arm and while not receiving metformin in the discontinuation arm",
                    "description": "Mean daily glucose levels will only be included for the days in which the subjects received or did not receive metformin as per their assigned arm.",
                    "timeFrame": "During hospitalization"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Adult (18+ years of age)\n* Admitted to an internal medicine service.\n* On Metformin prior to admission.\n\nExclusion Criteria:\n\n* Inability to take oral medications\n* eGFR \\< 30 ml/min/1.73 m2\n* Dialysis\n* Current Acidosis (pH \\< 7.35) including diabetic ketoacidosis\n* Child-Turcotte-Pugh class C hepatic cirrhosis\n* Acute Decompensated Heart Failure\n* Cognitively impaired and/or unable to consent\n* Lack of or unwillingness to share contact information\n* Pregnant women",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "maximumAge": "110 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "locations": [
                {
                    "facility": "University of Illinois at Chicago",
                    "city": "Chicago",
                    "state": "Illinois",
                    "zip": "60612",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 41.85003,
                        "lon": -87.65005
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000003924",
                    "term": "Diabetes Mellitus, Type 2"
                }
            ],
            "ancestors": [
                {
                    "id": "D000003920",
                    "term": "Diabetes Mellitus"
                },
                {
                    "id": "D000044882",
                    "term": "Glucose Metabolism Disorders"
                },
                {
                    "id": "D000008659",
                    "term": "Metabolic Diseases"
                },
                {
                    "id": "D000004700",
                    "term": "Endocrine System Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M7119",
                    "name": "Diabetes Mellitus, Type 2",
                    "asFound": "Diabetes Mellitus, Type 2",
                    "relevance": "HIGH"
                },
                {
                    "id": "M7115",
                    "name": "Diabetes Mellitus",
                    "relevance": "LOW"
                },
                {
                    "id": "M3499",
                    "name": "Acidosis",
                    "relevance": "LOW"
                },
                {
                    "id": "M11639",
                    "name": "Metabolic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M25403",
                    "name": "Glucose Metabolism Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M7862",
                    "name": "Endocrine System Diseases",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC18",
                    "name": "Nutritional and Metabolic Diseases"
                },
                {
                    "abbrev": "BC19",
                    "name": "Gland and Hormone Related Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000008687",
                    "term": "Metformin"
                }
            ],
            "ancestors": [
                {
                    "id": "D000007004",
                    "term": "Hypoglycemic Agents"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M11667",
                    "name": "Metformin",
                    "asFound": "Assessment",
                    "relevance": "HIGH"
                },
                {
                    "id": "M10054",
                    "name": "Hypoglycemic Agents",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "Hypo",
                    "name": "Hypoglycemic Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}